Status: current, Not sufficiently defined by necessary conditions definition status. Date: 29-Apr 2015. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 91401501000001119 | Sodium dihydrogen phosphate anhydrous 340mg / Sodium bicarbonate 250mg suppositories 10 suppository (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 91401601000001115 | Sodium dihydrogen phosphate anhydrous 340mg / Sodium bicarbonate 250mg suppositories 10 suppository | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Sodium dihydrogen phosphate anhydrous 340mg / Sodium bicarbonate 250mg suppositories 10 suppository | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| Sodium dihydrogen phosphate anhydrous 340mg / Sodium bicarbonate 250mg suppositories 10 suppository | Is a | Virtual medicinal product pack | true | Inferred relationship | Existential restriction modifier | ||
| Sodium dihydrogen phosphate anhydrous 340mg / Sodium bicarbonate 250mg suppositories 10 suppository | Has VMP | Sodium dihydrogen phosphate anhydrous 340mg / Sodium bicarbonate 250mg suppositories | true | Inferred relationship | Existential restriction modifier | ||
| Sodium dihydrogen phosphate anhydrous 340mg / Sodium bicarbonate 250mg suppositories 10 suppository | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| Sodium dihydrogen phosphate anhydrous 340mg / Sodium bicarbonate 250mg suppositories 10 suppository | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
| Sodium dihydrogen phosphate anhydrous 340mg / Sodium bicarbonate 250mg suppositories 10 suppository | Has specific active ingredient | Sodium bicarbonate | true | Inferred relationship | Existential restriction modifier | ||
| Sodium dihydrogen phosphate anhydrous 340mg / Sodium bicarbonate 250mg suppositories 10 suppository | Has specific active ingredient | Sodium dihydrogen phosphate anhydrous | true | Inferred relationship | Existential restriction modifier | ||
| Sodium dihydrogen phosphate anhydrous 340mg / Sodium bicarbonate 250mg suppositories 10 suppository | Has dispensed dose form | Suppository | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Lecicarbon C suppositories (Aspire Pharma Ltd) 10 suppository 2 x 5 suppositories | Is a | True | Sodium dihydrogen phosphate anhydrous 340mg / Sodium bicarbonate 250mg suppositories 10 suppository | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR